SAN FRANCISCO, Oct. 26, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced one-year results from CLASP IID, the first randomized controlled trial that directly compares two ...
Philips said Thursday it has received 510(k) clearance for a heart procedure visualization tool it developed with Edwards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results